openPR Logo
Press release

Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031

05-08-2021 11:12 AM CET | Health & Medicine

Press release from: Visiongain Research

Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031

Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios.

Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx bn in 2020 and is projected to grow at a CAGR of xx% during the forecast period 2021-2031.

Click here to Get Complete Synopsis of the Report @https://www.visiongain.com/report/ibd-drug-market-2021/

COVID-19 has a significant negative impact on the Inflammatory Bowel Disease Drugs Market
The COVID-19 pandemic has a negative impact on the IBD drug market globally. As a result of the COVID-19 outbreak, which has resulted in tight border controls, instability on the stock market, and country-wide lockdowns, this pandemic has hampered the production and distribution of IBD drugs.

How this report will benefit you
Visiongain’s 330+ page report provides 199 tables and 147 charts/graphs. Our new study is envisioned for anyone requiring commercial in-depth analyses for the global IBD drugs market along with detailed segment analysis in the market. Our new study assists you to evaluate the overall global and regional market for IBD drugs. Get the financial analysis of the overall market and different segments including drug class, indication, patient demographics, end-user, and distribution channel and capture higher market share. High opportunity remains in this fast-growing inflammatory bowel disease drugs market. See how to use the existing and upcoming opportunities in this market to gain revenue benefits in the near future. Moreover, the report would help you to improve your strategic decision-making, allows you to frame growth strategies, reinforce the analysis of other market players, and maximise the productivity of the company.

Forecasts to 2031 and other analyses reveal the commercial prospects
• Our new study provides you with revenue forecast by different segments including drug class, indication, and distribution channel to 2031
• It also includes growth rates for different 4 regional markets along with 11 countries and COVID-19 impact analysis on each market
• The profiles of the top 13 companies are very descriptive and comprehensive data including company snapshot, overview, commercial developments, company market shares, and detailed financial analysis with revenue and other financials

Download a Sample Report with Table of Contents and Figures by clicking here @https://www.visiongain.com/report/ibd-drug-market-2021/

• The COVID-19 has a positive impact on the IBD drugs industry and the report includes detailed analysis and invaluable insight into how COVID-19 will affect the industry.
Detailed profiles of 13 leading companies that are operating in the market
The report includes profiles of 13 major companies involved in the IBD drugs market. The companies profiled in this report include: AbbVie, Janssen Biotech, Allergan plc., Takeda Pharmaceuticals, Pfizer Inc., Novartis AG, UCB Pharma S.A., Biogen Inc., Gilead Sciences, Inc., F. Hoffmann-La Roche AG, Celgene Corporation, Celltrion Corporation, and Ferring B.V.

In summary, our 330+ page report delivers you with the following knowledge:
• Revenue forecasts from 2021 to 2031 for the global IBD drugs market and subsegments (by drug class, indication, distribution channel, and region)– discover the industry’s prospects, finding the most lucrative areas for investments and revenue generation
• Detailed profiles of top 13 IBD drugs manufacturers, with financial overviews
• Revenue forecasts from 2021 to 2031 for 4 regional markets – See forecasts for the IBD drugs market in the U.S., Japan, Europe5, BRIC, and RoW.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

Contact:
Address: Airport House, Purley Way, Surrey, London, CR0 0XZ United Kingdom
Name : Sara Peerun
Email: sara.peerun@visiongain.com
Phone: +44(0)2075499987
Research Insight: https://www.visiongain.com/report/ibd-drug-market-2021/

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent market research company in London, the company comprises over 400+ analysts and consultants, adding more than 1400 market research reports to its vast database each year. These reports offer in-depth analysis on 18 industries worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031 here

News-ID: 2281877 • Views: 408

More Releases from Visiongain Research

Integrated Traffic Systems Market Report Up to 2031
Visiongain has published a new report on Integrated Traffic Systems Market Report to 2031: Forecasts by Function (Traffic Monitoring & Control and Information Gathering) By Hardware Type (Display Boards, Surveillance Cameras, Traffic Lights, Interface Boards) By Services (Deployment & Integration and Maintenance) By Sensor Type (Infrared, Weigh-in Motion, and Acoustic Sensors). PLUS Profiles of Leading Integrated Traffic Systems Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery
Alopecia Market Research Report Up to 2031
Visiongain has published a new report on Alopecia Market Report to 2031: Forecasts by Disease Type (Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, and Alopecia Totalis), By Route of Administration (Oral, Topical, and Injectable), By Distribution Channel (Hospitals, Retail Pharmacies, and Online Pharmacies) PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/alopecia-market/#download_sampe_div COVID-19 Impact on Alopecia Market COVID-19 pandemic has affected more than 200 countries worldwide. Companies have been pressured
Bakery Processing Equipment Market Report Up to 2031
Visiongain has published a new report on Bakery Processing Equipment Market Report to 2031: Forecasts By Type (Ovens & Proofers, Mixers, Slicers & Dividers, Sheeters & Molders, Others), By Application (Cookies & Biscuits, Bread, Cakes & Pastries, Pizza Crusts, Others) PLUS Profiles of Leading Bakery Processing Equipment Manufacturing Companies and Regional and Leading National Market Analysis, PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/bakery-processing-equipment-market/#download_sampe_div The increasing urbanization coupled with
Ascorbic Acid Market Report Up to 2031
Visiongain has published a new report on Ascorbic Acid Market Report to 2031: Forecasts By Application (Food & Beverages, Chemicals, Personal Care, Pharma, Agriculture, Others), By Distribution Channel (Online Channels, Offline Channels) PLUS Profiles of Leading Ascorbic Acid Manufacturing Companies and Regional and Leading National Market Analysis, PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/ascorbic-acid-market/#download_sampe_div Ascorbic acid has a wide range of application in pharmaceutical, food & beverage and

All 5 Releases


More Releases for IBD

US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 …
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per
Indian IBD Therapeutics Market Growth, Opportunity, Size, Share and Forecast 201 …
Indian IBD therapeutics market is estimated to grow significantly at a CAGR of around 6.2% during the forecast period. The Indian pharmaceutical industry has been consistently growing with the public and private investments, making India as a potential market for the treatment of prevailing diseases such as IBD. Additionally, healthcare expenditure is playing a critical role in fueling the IBD therapeutics market in India. Request a Free Sample of our
Germany IBD Therapeutics Market will experience a noticeable growth during the f …
Germany IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.4% during the forecast period. The growing IBD patient population in the region is one of the major driving forces for the growth of the market in the country. According to the national institutes of health, the prevalence of Crohn's disease in Germany was estimated to be 322 per 100,000 in Germany in 2018. Moreover, the
Canada IBD Therapeutics Market, Industry Trends, Size, Competitive Analysis and …
Canada IBD Therapeutics market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn's disease,
Inflammatory Bowel Disease (IBD) Treatment Market will Exhibit a Steady 2.6% CAG …
Competition is expected to remain high from 2017 to 2025 in the global inflammatory bowel disease (IBD) treatment market. During this time, the market will witness a slew of launches as manufacturers invest in the development of novel therapeutics. According to a new study by Transparency Market Research (TMR), a paradigm shift toward biosimilar and biologic drugs is expected, which will offer a fresh burst of opportunities to the global
Global Inflammatory Bowel Disease (IBD) Treatment Market to Grow at 2.6% CAGR th …
A new thorough study titled “Inflammatory Bowel Disease (IBD) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025” has recently been submitted to the database of Market Research Reports Search Engine (MRRSE). The global inflammatory bowel disease treatment market is projected to grow at 2.6% CAGR through 2025. In terms of revenue, the market is anticipated to reach nearly US$ 15 Bn in revenues. Request Sample Copy